Corporate News     31-May-23
Board of Astrazeneca Pharma India recommends final dividend
Of Rs 16 per share
Astrazeneca Pharma India announced that the Board of Directors of the Company at its meeting held on 30 May 2023, inter alia, have recommended the final dividend of Rs 16 per equity Share (i.e. 800%) , subject to the approval of the shareholders.
Previous News
  Astrazeneca Pharma India standalone net profit rises 172.47% in the September 2022 quarter
 ( Results - Announcements 11-Nov-22   17:08 )
  Astrazeneca Pharma India standalone net profit declines 38.28% in the March 2023 quarter
 ( Results - Announcements 31-May-23   07:43 )
  Astrazeneca Pharma India standalone net profit rises 57.94% in the September 2019 quarter
 ( Results - Announcements 11-Nov-19   16:51 )
  Astrazeneca Pharma India to announce Quarterly Result
 ( Corporate News - 01-Nov-22   10:34 )
  AstraZeneca Pharma drops after UK parent pauses COVID-19 vaccine trial
 ( Hot Pursuit - 09-Sep-20   09:37 )
  AstraZeneca Pharma India appoints director
 ( Corporate News - 13-Aug-20   10:21 )
  Astrazeneca Pharma India to announce Quarterly Result
 ( Corporate News - 30-Jan-21   10:12 )
  Volumes spurt at AIA Engineering Ltd counter
 ( Hot Pursuit - 12-Nov-20   11:00 )
  Astrazeneca Pharma India reports standalone net profit of Rs 8.67 crore in the December 2015 quarter
 ( Results - Announcements 06-Feb-16   16:31 )
  Astrazeneca Pharma India to conduct board meeting
 ( Corporate News - 30-Jul-19   10:47 )
  Strides Pharma Science Ltd leads gainers in 'A' group
 ( Hot Pursuit - 30-Jul-19   12:00 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top